Targeted Leukemia Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved the first treatment to specifically target the B-cell lymphoma 2 (BCL-2) protein found in patients with chronic lymphocytic leukemia (CLL).
Hemophilia A Treatment Gets Green Light
The US Food and Drug Administration (FDA) has approved a new treatment for hemophilia A.
A New Formulation for Melphalan
The US Food and Drug Administration (FDA) approved a new formula of melphalan under the brand name Evomela to treat patients with multiple myeloma.
Another Hemophilia Treatment Option
Patients with hemophilia B, a rare, inherited bleeding disorder, may soon have another treatment option.
New Treatment Offers Hope for Multiple Myeloma
Multiple myeloma is a hard cancer to cure. But there may be some good news on that front.
Cancer Forecast: Leukemia on the Decline in 2016
According to new predictions, 2016 will be a good year for leukemia.
New Leukemia Rx Gets FDA Nod
Doctors may now have another tool in their arsenal for the treatment of chronic lymphocytic leukemia (CLL).
New VTE Guidelines Released
The American College of Chest Physicians (CHEST) issued some new guidelines for the treatment of venous thromboembolism (VTE).
Before Cancer Surgery, Blood Thinners Appeared Safe
Cancer patients have enough to worry about — they shouldn't have to worry about the health effects of medications taken before cancer surgery. And new evidence suggests they may not have to.
Novel Blood Clot Rx Shows Potential
Antiplatelet medications, while highly effective, can put surgical patients at risk of serious bleeding. But a new, safer drug may be on the horizon.